We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $195M
1-Year Est. Return 12.04%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$228M
AUM Growth
-$212K
Cap. Flow
-$4.85M
Cap. Flow %
-2.13%
Top 10 Hldgs %
51.84%
Holding
54
New
2
Increased
20
Reduced
27
Closed
3

Top Buys

Rank Stock Value
1
VVV icon
Valvoline
VVV
+$2.75M
2
ETN icon
Eaton
ETN
+$2.22M
3
DXCM icon
DexCom
DXCM
+$2M
4
PM icon
Philip Morris
PM
+$1.23M
5
AMZN icon
Amazon
AMZN
+$1.15M

Top Sells

Rank Stock Value
1
OWL icon
Blue Owl Capital
OWL
+$3.2M
2
UNH icon
UnitedHealth
UNH
+$2.99M
3
VCEL icon
Vericel Corp
VCEL
+$2.15M
4
TDG icon
TransDigm Group
TDG
+$1.98M
5
PWR icon
Quanta Services
PWR
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Financials 17.2%
3 Consumer Discretionary 14.41%
4 Communication Services 12.54%
5 Industrials 11.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
26
Zoetis
ZTS
$32B
$3.14M 1.38%
21,468
-1,818
-8% -$275K
CASY icon
27
Casey's General Stores
CASY
$32.4B
$3.12M 1.37%
5,513
-82
-1% -$42.9K
TTEK icon
28
Tetra Tech
TTEK
$8.34B
$3.11M 1.37%
93,235
-17,818
-16% -$648K
WYNN icon
29
Wynn Resorts
WYNN
$10.2B
$2.89M 1.27%
22,544
+107
+0.5% +$12.4K
OLLI icon
30
Ollie's Bargain Outlet
OLLI
$4.44B
$2.86M 1.26%
22,295
-181
-0.8% -$24K
DKNG icon
31
DraftKings
DKNG
$11.6B
$2.68M 1.18%
71,579
+1,302
+2% +$57.7K
VVV icon
32
Valvoline
VVV
$4.86B
$2.59M 1.14%
+72,165
New +$2.75M
UNH icon
33
UnitedHealth
UNH
$382B
$2.34M 1.03%
6,773
-9,877
-59% -$2.99M
ETN icon
34
Eaton
ETN
$154B
$2.29M 1.01%
+6,113
New +$2.22M
DXCM icon
35
DexCom
DXCM
$31.7B
$2.15M 0.94%
31,947
+25,261
+378% +$2M
PEN icon
36
Penumbra
PEN
$12.6B
$2M 0.88%
7,879
-187
-2% -$47.2K
CWAN
37
DELISTED
Clearwater Analytics
CWAN
$1.83M 0.8%
101,611
-2,325
-2% -$47.1K
AVGO icon
38
Broadcom
AVGO
$1.83T
$1.4M 0.62%
4,248
+14
+0.3% +$4.29K
SPY icon
39
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$697K 0.31%
1,046
-10
-0.9% -$6.41K
LMT icon
40
Lockheed Martin
LMT
$133B
$487K 0.21%
975
-25
-3% -$11.3K
TJX icon
41
TJX Companies
TJX
$174B
$446K 0.2%
3,085
+325
+12% +$43.2K
AAPL icon
42
Apple
AAPL
$4.43T
$432K 0.19%
1,696
+30
+2% +$6.78K
SHW icon
43
Sherwin-Williams
SHW
$82.4B
$398K 0.17%
1,150
FNV icon
44
Franco-Nevada
FNV
$41.3B
$357K 0.16%
1,600
+125
+8% +$22.5K
NEE icon
45
NextEra Energy
NEE
$183B
$352K 0.15%
4,659
+200
+4% +$14.6K
COST icon
46
Costco
COST
$421B
$324K 0.14%
350
-100
-22% -$95.9K
HON icon
47
Honeywell
HON
$76.8B
$285K 0.13%
1,438
+106
+8% +$22.1K
LAMR icon
48
Lamar Advertising Co
LAMR
$16.1B
$264K 0.12%
2,158
+110
+5% +$13.7K
PFE icon
49
Pfizer
PFE
$142B
$256K 0.11%
10,062
-4,000
-28% -$98.7K
APYX icon
50
Apyx Medical
APYX
$170M
$42.8K 0.02%
20,000

Similar funds

Scholtz & Company's Q3 2025 Portfolio in Review

As of Q3 2025, Scholtz & Company held 54 positions worth $228M, down 0.09% from $228M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Scholtz & Company's Q3 2025 filing shows 2 new, 20 increased, 27 reduced and 3 closed positions. Its largest new stake was Valvoline: 72,165 shares worth $2.59M. The largest sale was Blue Owl Capital, an estimated $3.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Scholtz & Company's largest Q3 2025 buy was Valvoline: 72,165 shares worth $2.59M.
  • Scholtz & Company added most to DexCom in Q3 2025, an estimated $2M increase.
  • Scholtz & Company's biggest Q3 2025 reduction was UnitedHealth, cutting an estimated $2.99M.
  • Scholtz & Company fully exited Blue Owl Capital in Q3 2025, selling an estimated $3.2M.
  • Scholtz & Company's ten largest holdings make up 52% of its $228M portfolio in Q3 2025.
  • Scholtz & Company opened 2 new positions and closed 3 in Q3 2025.
  • Scholtz & Company's portfolio value fell 0.09% quarter-over-quarter to $228M.

Based on Scholtz & Company's 13F filing for Q3 2025, filed 12 Nov 2025.